The MedImmune spinout is targeting inflammation and autoimmune diseases, and will be equipped with up to $250m of series A funding.

The Illumina cancer testing spinout, which counts a range of other corporates as investors, is talking to advisers about a flotation this year.

Strategic partner Omron and existing backer Rakuten have invested $15.4m in the genetic testing services provider at a $392m valuation.

Maher Khaled, who managed intellectual property arising from medical research at University of Queensland, has joined Preveceutical Medical as director of international operations.

The Medical Research Commercialisation Fund has supplied series A capital to Okogen as the company partners University of Sydney to develop a treatment for viral conjunctivitis.

The heart monitoring platform has boosted its series C round to $37.1m, having reached a 2016 first close that included OSF Healthcare.

Paul Santerre, professor at the Faculty of Dentistry, has been named Baxter chair of health technology and commercialisation.